第一医药：2025年第三季度归属于上市公司股东的净利润同比增长123.80%

Core Insights - The company reported a revenue of 542,480,778.50 yuan for the third quarter of 2025, representing a year-on-year growth of 14.04% [1] - The net profit attributable to shareholders of the listed company was 39,245,693.69 yuan, showing a significant year-on-year increase of 123.80% [1]